Juan Sanchez insider trades
Open-market stock purchases and sales by Juan Sanchez, Director at Nuvectis Pharma, Inc, from SEC Form 4 filings since Sep 22, 2025.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +65%.
Companies traded
- NVCT Nuvectis Pharma, Inc: 1 buy, last Jun 11, 2026